These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27279145)

  • 1. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
    Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
    Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
    Gong X; Tang H; Yang K
    Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
    Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
    Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest.
    Yu CC; Huang HB; Hung SK; Liao HF; Lee CC; Lin HY; Li SC; Ho HC; Hung CL; Su YC
    PLoS One; 2016; 11(3):e0151942. PubMed ID: 27031247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
    Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
    Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
    Yang G; Yang Y; Tang H; Yang K
    Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR /AKT/ERK1/2 pathway.
    Remadevi V; Jaikumar VS; Vini R; Krishnendhu B; Azeez JM; Sundaram S; Sreeja S
    Phytomedicine; 2024 Jul; 130():155721. PubMed ID: 38788395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
    Yang Y; Chen D; Liu H; Yang K
    Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.
    Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
    Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.
    Chaisuparat R; Limpiwatana S; Kongpanitkul S; Yodsanga S; Jham BC
    J Oral Pathol Med; 2016 Sep; 45(8):581-5. PubMed ID: 26775690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.
    Dan H; Liu S; Liu J; Liu D; Yin F; Wei Z; Wang J; Zhou Y; Jiang L; Ji N; Zeng X; Li J; Chen Q
    Mol Oncol; 2020 Apr; 14(4):795-807. PubMed ID: 31997535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
    Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
    Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
    Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling.
    Xu L; Li J; Tursun M; Hai Y; Tursun H; Mamtimin B; Hasim A
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
    Sun S; Cui Z; Yan T; Wu J; Liu Z
    Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RACK1 is an organ-specific prognostic predictor in OSCC.
    Liu S; Liu J; Wang J; Cheng J; Zeng X; Ji N; Li J; Chen Q
    Oral Oncol; 2018 Jan; 76():22-26. PubMed ID: 29290282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.